{"slideshow_credits": null, "snippet": "There is already a bipartisan framework that would stop corporate inversions like the Pfizer deal and keep the tax revenue here.", "abstract": "Op-Ed article by Carl C Icahn urges Congress to reform taxation of American companies' earnings abroad; promotes bipartisan measure which would sharply reduce tax rate on foreign revenue, encourage companies to repatriate funds currently left abroad and help prevent corporations from relocating overseas to avoid onerous taxes. ", "section_name": "Opinion", "print_page": "23", "document_type": "article", "byline": {"person": [{"lastname": "ICAHN", "rank": 1, "firstname": "Carl", "role": "reported", "organization": "", "middlename": "C."}], "original": "By CARL C. ICAHN"}, "web_url": "http://www.nytimes.com/2015/12/14/opinion/how-to-stop-turning-us-corporations-into-tax-exiles.html", "lead_paragraph": "There is already a bipartisan framework that would stop corporate inversions like the Pfizer deal and keep the tax revenue here.", "headline": {"print_headline": "Bring the Corporate Tax Exiles Home", "main": "How to Stop Turning U.S. Corporations Into Tax Exiles", "content_kicker": "Op-Ed Contributor", "kicker": "Op-Ed Contributor"}, "_id": "566e7bc538f0d83e10be1579", "word_count": "950", "multimedia": [{"height": 126, "url": "images/2015/12/14/opinion/14icahnWeb/14icahnWeb-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/12/14/opinion/14icahnWeb/14icahnWeb-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 455, "url": "images/2015/12/14/opinion/14icahnWeb/14icahnWeb-articleLarge.jpg", "legacy": {"xlarge": "images/2015/12/14/opinion/14icahnWeb/14icahnWeb-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "455"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/12/14/opinion/14icahnWeb/14icahnWeb-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/12/14/opinion/14icahnWeb/14icahnWeb-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-12-14T00:00:00Z", "source": "The New York Times", "news_desk": "OpEd", "keywords": [{"name": "subject", "value": "Corporate Taxes", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "11"}, {"name": "subject", "value": "Tax Shelters", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Pfizer Inc", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Allergan Inc", "is_major": "N", "rank": "4"}, {"name": "persons", "value": "Portman, Rob", "is_major": "N", "rank": "5"}, {"name": "persons", "value": "Schumer, Charles E", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "House Committee on Ways and Means", "is_major": "N", "rank": "7"}, {"name": "persons", "value": "Ryan, Paul D Jr", "is_major": "N", "rank": "8"}, {"name": "persons", "value": "Brady, Kevin (1955- )", "is_major": "N", "rank": "9"}, {"name": "persons", "value": "Clinton, Hillary Rodham", "is_major": "N", "rank": "10"}], "blog": [], "subsection_name": null, "type_of_material": "Op-Ed"}